Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
LSD-assisted Psychotherapy in Persons Suffering From Anxiety Associated With Advanced-stage Life Threatening Diseases. A Phase-II, Double-blind, Placebo-controlled Dose-response Pilot Study
Sponsor: Multidisciplinary Association for Psychedelic Studies
Listed as NCT00920387, this PHASE2 trial focuses on Anxiety and remains completed. Sponsored by Multidisciplinary Association for Psychedelic Studies, it has been updated 12 times since 2008, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2023 — Aug 2023 [monthly]
Completed PHASE2
-
Sep 2022 — Jun 2023 [monthly]
Completed PHASE2
▶ Show 7 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Completed PHASE2
-
Feb 2022 — Apr 2022 [monthly]
Completed PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Completed PHASE2
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Multidisciplinary Association for Psychedelic Studies
For direct contact, visit the study record on ClinicalTrials.gov .